For the Quarter Ending March 2025
North America
During the first quarter of 2025, the Coenzyme Q10 (CoQ10) market in North America followed a progressively upward pricing trend, influenced by a convergence of macroeconomic adjustments, trade policy changes, and evolving downstream sector demand. In January, prices experienced steady increases as pharmaceutical, nutraceutical, and cosmetic industries ramped up procurement activities, partly driven by heightened holiday season consumption and precautionary buying in anticipation of new regional trade regulations.
The announcement of additional import tariffs on selected Asian-origin chemical products amplified inflationary pressures within the market, prompting distributors and buyers to advance their purchasing cycles to avoid impending cost escalations. This speculative buying activity strengthened the market’s bullish sentiment. In February, pricing pressures persisted despite relatively balanced trading activity and inventory levels. A newly enforced 10% tariff on imports from key manufacturing hubs, alongside a sharp increase in ocean freight rates to both eastern and western coasts, kept import costs elevated, which translated into higher market prices.
By March, prices maintained their upward momentum, supported by improving consumer sentiment and modest inflationary relief. Additionally, the depreciation of the regional currency against major exporting nations’ currencies compounded import costs, contributing to the bullish pricing climate. Overall, Q1 2025 concluded with sustained CoQ10 price increases in North America, steered by resilient downstream demand, escalated import expenses, and tactical purchasing behaviours in response to evolving trade frameworks and macroeconomic shifts.
Asia Pacific
Throughout the first quarter of 2025, the Coenzyme Q10 (CoQ10) market in the Asia Pacific region navigated a dynamic pricing environment shaped by seasonal manufacturing cycles, shifting international demand trends, and broader economic adjustments. In January, market prices held firm, supported by sustained domestic and export-oriented production activities as regional manufacturing sentiment remained positive. Seasonal festivities during this period, coupled with logistical challenges and temporary factory shutdowns in several areas, created short-lived supply constraints, providing limited upward price support.
However, as February commenced, prices experienced slight corrections amid softening international demand, notably from North American and European markets. The post-holiday production resumption led to a swift increase in capacity utilization rates, which, in combination with modest downstream inquiries, resulted in excess supply and contributed to moderate downward pricing pressure. This trend was temporary, as by March, renewed buying interest from key international markets revitalized overall sentiment within the region.
Export demand, particularly from pharmaceutical and nutraceutical sectors abroad, drove manufacturers to align production schedules with surging overseas requirements. While domestic consumption remained stable, the resurgence in international orders prompted price recoveries toward the quarter’s end. Consequently, the Asia Pacific CoQ10 market concluded Q1 2025 with marginal net gains, reflecting a complex interplay between seasonal production adjustments, inventory repositioning, and fluctuating export demand patterns.
Europe
In Europe, the Coenzyme Q10 (CoQ10) market exhibited a generally upward pricing trend across the first quarter of 2025, primarily propelled by consistent demand from the pharmaceutical and nutraceutical industries, coupled with favourable foreign exchange movements and gradually improving logistical conditions. During January, market prices remained relatively stable, supported by steady downstream procurement and moderate inventory positions among distributors and importers. Despite ongoing logistical disruptions and fluctuating exchange rates, the market maintained a balanced position as downstream demand held firm.
By February, pricing began to reflect gradual increases as inquiries from key buyers intensified. Manufacturers and procurement specialists strategically augmented their purchasing volumes to shield against expected cost escalations linked to international trade policy changes and persistent supply chain constraints. In March, the market experienced notable upward momentum as downstream demand surged, particularly from pharmaceutical and supplement manufacturers preparing for second-quarter consumption peaks. Although a slight decline in freight rates partially eased import costs, global price firming driven by higher raw material expenses continued to exert upward pressure on European market prices.
Additionally, the strengthening of the regional currency against the U.S. dollar enhanced import competitiveness but did not fully counterbalance the broader inflationary effects of rising international product costs. As Q1 2025 concluded, European CoQ10 prices reflected a clear net increase, driven by resilient demand fundamentals, improving logistics, and advantageous currency positioning amidst a globally tightening supply environment.
For the Quarter Ending December 2024
North America
During the entire the fourth quarter of 2024, the U.S. CoQ-10 market exhibited marked bearish trends, driven by weak demand and ongoing manufacturing contraction in end-user sectors. The market remained well supplied, with minimal disruptions to the supply chain and cautious purchasing from downstream buyers. Efforts to stimulate demand through price reductions were largely ineffective, as sales volumes stayed low and inventory levels remained sufficient. Smaller market players faced growing pressures, leading to increased consolidation as larger firms made moves to acquire or absorb them. A notable supply surplus emerged, further exacerbating the downturn. Suppliers adopted aggressive pricing strategies, offering discounts to manage excess stock. While manufactures across the region showed flexibility in negotiations for future orders, reflecting the challenges in predicting demand shifts. The combination of weak demand and oversupply created a complex trading environment, underscoring a market in decline as it struggled to adapt to broader economic pressures.
Asia Pacific
The CoQ10 market in China during Q4 2024 exhibited complex dynamics, influenced by economic conditions and supply-demand factors. In October, the market remained stable, with prices holding steady from previous periods due to consistent demand and upstream conditions. The temporary slowdown from the Golden Week holiday helped maintain equilibrium. Demand was generally stable but weakened slightly due to global economic challenges, which impacted consumer sentiment and led to more cautious procurement, especially in key regions. In November, post-holiday operations saw a modest rise in procurement, driven by preparations for the winter season. However, increasing supply-side pressures, including elevated inventory levels and plant shutdowns, weighed on the market. The appreciation of the yuan also mitigated price increases, benefiting importers. By December, demand from both regional and international nutraceutical sectors slowed, worsening the oversupply situation. With economic uncertainties, consumer purchasing remained conservative, prompting price declines as suppliers aimed to clear excess stock. This resulted in declining transaction volumes and continued bearish conditions, reflecting earlier market trend as December concludes.
Europe
Following a similar market trend as that of other importing nations, during the entire Q4 of 2024, Germany's CoQ-10 export market experienced sustained price declines, primarily driven by weak downstream demand and an unfavorable cost environment. The downstream Nutra and supplement sector, a key consumer, exhibited majorly reduced procurement activity as buyers prioritized essential purchases and maintained minimal inventories. The euro's depreciation further compounded challenges, raising the cost of imports and dampening new orders, which reinforced bearish market sentiment. However, the manufacturing sector showed modest signs of recovery, with the Manufacturing PMI increasing from 40.6 in September to 43 in October, signaling a less severe contraction. Despite this, the global competition intensified as APAC exporters benefited from lower feedstock costs, including declining CoQ-10 prices, exerting downward pressure on the overall production of CoQ-10 exp in key producing regions which has a direct impact on Germany's import prices. As a result, persistent high inventory levels, combined with restrained purchasing activity, led to oversupply, prompting suppliers to adopt aggressive pricing strategies to clear stock. Lastly, despite seasonal disruptions such as port delays and labor shortages, the muted demand largely mitigated their impact. By December, the market was firmly in buyers' favor, with suppliers relying on price reductions and flexible strategies to manage oversupply the overall import prices for CoQ-10.
For the Quarter Ending September 2024
North America
Throughout Q3 2024, the CoQ10 market in North America experienced a significant decline in prices, influenced by a multitude of factors. The downward trend was primarily driven by subdued demand from downstream industries, leading to weak overall market dynamics.
Factors such as ample availability weakened regional and overseas demand, and cautious purchasing behavior contributed to the negative pricing environment. As a result, the export market has continued to perform weakly concerning market sales. While, at the same time manufacturers were focused on reducing their further stockpiles as the month concluded, thereby supporting a further drop in the prices.
Overall, across the United States, witnessing a substantial price change, the market on a quarter-on-quarter basis demonstrated a drop of an average of 2 percent further highlighting the declining trend, indicating a consistent downward trajectory. The quarter-ending price of USD 174000/MT of CoQ10 99% CIF-Los Angeles in the USA encapsulates the overall negative sentiment and challenging pricing environment experienced during Q3 2024.
APAC
While on the Asia Pacific side, during the entire Q3 2024, the APAC region witnessed a notable decline in CoQ10 prices, with significant factors contributing to this downward trend. Oversupply situations, subdued demand from key industries, and increased production capacities were key influences on market prices. In China specifically, the market experienced the most significant price changes. With inventory levels surpassing market forecasts, suppliers resorted to price reductions as a strategic measure to clear surplus stocks. This oversupply scenario prompted merchants to implement discounts, particularly on bulk purchases, to stimulate demand and prepare for future replenishments. While on the trade side, the market witnessed a steady drop in freight cost, thereby easing the overall import cost. Despite this ease in the freight cost, the downstream trading sentiments remained on the lower side as inquiries from end-users remained low and buyers were highly resistant to further procurement. As a result, Manufacturers focused on further weakening their profit sentiment, thereby focusing on clearing their inventories yet demonstrating a continuous pessimistic market sentiment. As a result following a quarter-on-quarter the prices dropped by an average of 3 percent during the entire third quarter, indicating a continued downward trajectory. The latest price of USD 155000/MT of CoQ10 Ex-Shanghai in China marked the quarter-ending price. The market sentiment throughout the quarter remained negative, with prices consistently decreasing. Seasonality and correlation played a role in the price changes, aligning with a weakening pricing environment characterized by oversupply and muted demand across the region.
Europe
Similar to that of other nations, the Q3 2024, the CoQ10 market in Europe also marked a decline in prices, largely driven by muted demand, global supply chain disruptions, and rising production costs. Germany, a key player in the European market, experienced the sharpest price drops, reflecting the broader negative market sentiment. This was not just a regional issue but one that mirrored global economic trends, including inflationary pressures and a slowdown in growth. For German traders and buyers, the impact of currency depreciation was particularly pronounced, potentially leading to a restructuring of supply chains. This could have meant a shift towards localized production or alternative sourcing strategies to mitigate the risks associated with currency fluctuations and rising costs. Looking ahead, the CoQ-10 market was expected to undergo significant changes, with an increased emphasis on cost optimization, efficiency in production processes, and potentially a push towards innovation. With a persistent drop in regional quotations, downstream traders were actively focused on reducing their inventories, resulting in clearing the stockpiles at a lower cost. Prices fell significantly by -2% compared to Q2 2024, signaling a major shift in market dynamics. By the end of Q3, CoQ10 prices stood at USD 179,000 per metric ton, CFR Hamburg, illustrating the ongoing challenges faced by the market, as both demand and pricing weakened substantially.
For the Quarter Ending June 2024
North America
In Q2 2024, the CoQ10 pricing landscape in North America exhibited a pronounced negative sentiment, marked by an overall downturn with a steady rise witnessed in the middle of the quarter. Several significant factors contributed to this decline, including an oversupply situation, weak demand from end-user industries, and logistical challenges. The proactive expansion of CoQ10 stocks by suppliers, in anticipation of heightened inquiries, resulted in excessive inventory levels. This strategic production adjustment, combined with weakened import activities, exacerbated the market's oversupply condition. Additionally, the rising freight transportation costs further strained the market, compelling businesses to reassess their pricing strategies, which in turn dampened consumer purchasing behaviour. Focusing exclusively on the USA, the market experienced the most pronounced price changes. The overall trend for Q2 2024 was characterized by subdued market trading and a consistent focus on inventory reduction by suppliers. The seasonality factor, coupled with an increase in operational expenses, added complexity to the pricing dynamics. The quarter's price change remained stable at 0% when compared to the previous quarter in 2024, indicating a persistent negative sentiment.
APAC
The second quarter of 2024 has witnessed an overall downward trend in CoQ10 prices across the APAC region, influenced by several critical factors. Increased production levels, surplus inventories, and strategic destocking initiatives have been the primary drivers of this price decline. Suppliers have been compelled to reduce prices to clear excess stocks, anticipating changing climatic conditions impacting storage and transportation. Intensified market competition and a significant rise in domestic production have further exacerbated this downward pressure. Focusing on China, which experienced the most pronounced price changes, the overall trend has been markedly bearish. However, the market witnessed a steady upward trend during the middle of the quarter where the country witnessed a modest rise in overseas inquiries particularly those from key nutraceuticals, supplements and other sectors. While the overall rise in inquiries were successfully balanced by already stocked up inventories. Traders were successfully balancing the demand side by trading their inventories at a higher rate during the month. This was further supported by rise in freight charges ahead of trade disputes which kept the overall exports from China on the northerly side. Overall, with this mixed trajectory, the market sentiments concerning the CoQ-10 remained on the lower side, resulting in a balanced supply-demand outlook. From the previous quarter in 2024, prices saw a moderate 2% decline, indicating a continuation of the negative sentiment.
Europe
In Q2 2024, the CoQ10 market in Europe experienced a downward trend influenced by a confluence of global and regional factors. The overall stability in CoQ10 pricing was primarily driven by balanced supply-demand dynamics and a low to moderate influx of imports from major exporting nations. Key considerations included sustained production levels in Asia, particularly from China, which maintained a consistent supply of CoQ10 at competitive rates. Additionally, Enterprises, grappling with escalating costs associated with storage and the inherent risk of product deterioration, have commenced releasing their stockpiled Coq-10 into the market. This strategic manoeuvre has augmented the available supply for buyers, further exerting downward pressure on prices. Focusing on Germany, which witnessed the most significant price fluctuations, the quarter was characterized by a weaken pricing trajectory. The CoQ10 market in Germany displayed resilience against broader economic challenges, including inflation and currency depreciation. Notably, the prices remained unchanged from the previous quarter, reflecting a 0% variance, and showed a significant year-over-year decrease of 27%, underscoring the stability achieved despite past volatility. This stability was facilitated by an adequate supply chain and moderate demand from end-user industries, ensuring equilibrium in the market. The stable sentiment in Germany's CoQ10 pricing environment suggests a well-balanced market, neither overly positive nor negative, but rather consistently stable, providing a predictable landscape for stakeholders.
